ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5000 participants.
Also called NCT06676280
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 5,000 participants
- Sponsor
- Jung-min Ahn
- Registry
-
NCT06676280
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT06676280. Randomized; no masking; primary purpose prevention. Start 2025-07-24 (actual); primary completion 2035-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
- Acronym
- ASA-3C
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- High-intensity statin
- Intervention (Drug)
- Guideline-directed statin therapy
- Lead sponsor
- Jung-min Ahn
Record details
- Record id
cardio:ct-nct06676280- Content hash
17fee4ea9d20ffd38aeb185d2e8c492f2ed08e7d9dedba29063dca0129438374